Rituximab + Immunotherapy in Follicular Lymphoma
Clinical trial NCT03636503 · TERMINATED
Trial details
- NCT number
- NCT03636503
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2021-07-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.